Jin Eun Choi
Overview
Explore the profile of Jin Eun Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1758
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blechter B, Hsiung C, Wang X, Zhang H, Seow W, Shi J, et al.
J Thorac Oncol
. 2024 Nov;
PMID: 39581378
We assessed the association between a genome-wide polygenic risk score (PRS) developed for lung adenocarcinoma (LUAD) risk and mutation on the EGFR gene in 998 East Asian never-smoking female LUAD...
2.
Blechter B, Wang X, Shi J, Shiraishi K, Choi J, Matsuo K, et al.
medRxiv
. 2024 Jul;
PMID: 38978671
Polygenic risk scores (PRSs) are promising for risk stratification but have mainly been developed in European populations. This study developed single- and multi-ancestry PRSs for lung adenocarcinoma (LUAD) in East...
3.
Yoo S, Lee S, Choi J, Hong M, Do S, Lee J, et al.
J Korean Med Sci
. 2023 Nov;
38(45):e381.
PMID: 37987107
Background: Neurogenic differentiation 1 (NeuroD1) is a representative small cell lung cancer (SCLC) transcription regulator involved in the carcinogenesis and behavior of SCLC. Histone modifications play an important role in...
4.
Yoo S, Do S, Choi J, Kang H, Hong M, Lee J, et al.
Oncology
. 2023 Aug;
102(1):67-75.
PMID: 37527640
Introduction: Altered lipid metabolism has been reported to be associated with prognosis in multiple cancers. This study aimed to investigate the association of polymorphisms in lipid metabolism pathway genes with...
5.
Lee J, Park J, Hong M, Choi J, Kang H, Do S, et al.
Thorac Cancer
. 2023 Jul;
14(26):2678-2686.
PMID: 37519036
Background: Necroptosis is a regulated inflammatory cell death which plays a significant role in cancer development and progression. In this study, we evaluated whether genetic variants in key regulators of...
6.
Shi J, Shiraishi K, Choi J, Matsuo K, Chen T, Dai J, et al.
Nat Commun
. 2023 May;
14(1):3043.
PMID: 37236969
Lung adenocarcinoma is the most common type of lung cancer. Known risk variants explain only a small fraction of lung adenocarcinoma heritability. Here, we conducted a two-stage genome-wide association study...
7.
Lee S, Yoo S, Choi J, Hong M, Do S, Lee J, et al.
Thorac Cancer
. 2023 Mar;
14(13):1145-1152.
PMID: 36935366
Background: Neurogenic differentiation factor 1 (NEUROD1) is frequently overexpressed in small-cell lung cancer (SCLC). NEUROD1 plays an important role in promoting malignant behavior and survival. Methods: In this study, we...
8.
Choi J, Jeon H, Wee H, Lee J, Lee W, Lee S, et al.
Thorac Cancer
. 2023 Mar;
14(11):1012-1020.
PMID: 36869643
Background: Despite therapeutic advances, lung cancer prognosis remains poor. Loss of heterozygosity (LOH) in the 3p21 region is well documented in lung cancer, but the specific causative genes have not...
9.
Hong M, Park J, Lee S, Lee J, Choi J, Kang H, et al.
J Cancer
. 2023 Jan;
13(15):3701-3709.
PMID: 36606188
Pemetrexed is an anti-folate agent which is one of the most frequently used chemotherapy agents for non-squamous non-small cell lung cancer (NSCLC) patients. However, clinical response to pemetrexed chemotherapy and...
10.
Lee Y, Do S, Lee S, Kang H, Choi J, Hong M, et al.
Oncology
. 2022 Oct;
101(2):96-104.
PMID: 36257285
Objective: This study was conducted to investigate the association between genetic variants in histone modification regions and clinical outcomes of PEM chemotherapy in patients with lung adenocarcinoma. Methods: Potentially functional...